LLY, COIN, HOOD, and ROKU Stocks in Focus: Cathie Wood Sells Winners and Buys New Catalysts — 6/18/26
I'm LongbridgeAI, I can summarize articles.ARK Invest's Cathie Wood sold significant stakes in Robinhood and Roku to lock in gains following positive news and acquisition rumors. Proceeds were used to buy Eli Lilly, Coinbase, and Block, betting on their growth drivers like new product launches and market expansion. Analysts view Generate Biomedicines and Strata Critical Medical favorably, while expressing caution on Robinhood and Twist Bioscience.
ARK's daily trade report for June 17 showed Cathie Wood moving capital across several high-profile names. The firm trimmed positions in Robinhood Markets (HOOD) and Roku (ROKU) while adding to Eli Lilly (LLY) and Coinbase Global (COIN). The trades suggest Wood used recent gains in some holdings to free up cash for stocks tied to new growth drivers. ARK also added to Block (XYZ) and made smaller changes across several biotech names.
Claim 55% Off TipRanks
High conviction on ARKK? Try Tradr's TARK or SARKWhy ARK Cuts Robinhood and Roku Stocks
Robinhood was one of ARK's largest sales of the day. The firm sold 275,572 shares through the ARK Innovation ETF (ARKK) for about $26.65 million. A day earlier, Robinhood announced plans to cut about 10% of its workforce, or roughly 300 jobs. The stock climbed 8.8% as investors welcomed the move and analysts raised their price targets. Wood appears to have used the rally to lock in gains.
Roku was another major source of cash. ARK sold 239,267 shares across the ARK Innovation ETF (ARKK), ARK Next Generation Internet ETF (ARKW), and ARK Fintech Innovation ETF (ARKF), worth about $33.01 million. The sale follows other reductions earlier this week. On June 15, Fox (FOX) agreed to acquire Roku in a $22 billion deal valued at $160 per share. With the stock trading near the offer price, Wood appears to have used the deal to trim her position.
Eli Lilly and Coinbase Lead ARK's Buying
Eli Lilly was ARK's largest purchase of the session. The firm bought 41,138 shares through the ARK Genomic Revolution ETF (ARKG), investing about $46.18 million. The buy came after Lilly acquired neuroscience firm 4E Therapeutics. Wood appears to have used the recent pullback in the stock to add to her position.
ARK also bought 111,799 Coinbase shares across ARKK, ARKW, and ARKF for about $18.92 million. The crypto exchange has been expanding beyond digital asset trading. Recent moves include the launch of tokenized U.S. stocks and an AI-powered investment tool for users outside the U.S. Wood appears to be betting on Coinbase's push into new markets.
Beyond the headline trades, ARK purchased 236,759 shares of Block worth about $17.68 million. The firm also added smaller positions in Alamar Biosciences (ALMR) and Generate Biomedicines (GENB), while trimming Strata Critical Medical (SRTA) and Twist Bioscience (TWST).
How Wall Street Views ARK's Latest Trades
Among ARK's latest trades, Generate Biomedicines offers the highest analyst upside at 83%, followed by Strata Critical Medical at 58% and Alamar Biosciences at 49%. At the other end, analysts see 3% downside in Robinhood and 13% downside in Twist Bioscience based on consensus price targets.